Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07290894 |
| Title | Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 (MITO VULVA-01) |
| Acronym | MITO VULVA-01 |
| Recruitment | Not yet recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute, Naples |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Nation Cancer Institute of Naples, Division of Medical Oncology - Uro-Gynecology Department, Naples | Napoli | 80131 | Italy | Details |